Gilead Sciences
GILD
#106
Rank
S$233.48 B
Marketcap
S$188.30
Share price
0.17%
Change (1 day)
22.57%
Change (1 year)

EPS for Gilead Sciences (GILD)

EPS in 2026 (TTM): S-$3.41

According to Gilead Sciences's latest financial reports the company's current EPS (TTM) is S-$3.33. In 2025 the company made an earnings per share (EPS) of S$8.77 an increase over its 2024 EPS that were of S$0.49.

EPS history for Gilead Sciences from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S-$3.41-138.87%
2025S$8.771702.63%
2024S$0.49-91.65%
2023S$5.8223.98%
2022S$4.70-25.86%
2021S$6.344850%
2020S$0.13-97.64%
2019S$5.430.9%
2018S$5.3818.71%
2017S$4.53-64.88%
2016S$12.90-18.45%
2015S$15.8255.28%
2014S$10.19296.02%
2013S$2.5717.89%
2012S$2.18

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
S$11.18-435.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$0.97-129.23%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
S$4.57-237.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$38.25-1,249.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$20.76-723.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
S$7.27-318.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
S$6.93-308.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
S$22.18-766.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$1.62-148.67%๐Ÿ‡บ๐Ÿ‡ธ USA